New Immune-Boosting drug enters human trials for tough cancers
NCT ID NCT07115043
Summary
This early-stage study aims to find a safe and effective dose of a new drug called AZD6750, which is designed to boost the immune system to fight cancer. It will test the drug alone and combined with other cancer treatments in about 60 adults with advanced or spreading solid tumors, including melanoma, lung, and breast cancers. The main goals are to check for side effects, see how the drug behaves in the body, and get an early look at whether it helps shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
Research Site
RECRUITINGSt Louis, Missouri, 63110, United States
-
Research Site
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
Research Site
RECRUITINGHouston, Texas, 77030, United States
-
Research Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Research Site
RECRUITINGFairfax, Virginia, 22031, United States
-
Research Site
RECRUITINGEast Melbourne, 3002, Australia
-
Research Site
RECRUITINGChūōku, 104-0045, Japan
-
Research Site
RECRUITINGKashiwa, 227-8577, Japan
-
Research Site
NOT_YET_RECRUITINGSeoul, 03080, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 06351, South Korea
Conditions
Explore the condition pages connected to this study.